TDP-43
TDP-43 is a protein involved in some frontotemporal and related diseases. It is a research target, not a licensed treatment.
Overview
Pathology helps explain FTD heterogeneity. It does not yet yield an approved medicine.
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · TDP-43 is a protein involved in some frontotemporal and related diseases. It is a research target, not a licensed treatment.
- 1 · What it is
TDP-43 is a protein involved in some frontotemporal and related diseases. It is a research target, not a licensed treatment.
- 2 · What goes wrong in cancer
RNA-binding protein that mislocalises in some FTD and related diseases.
- 3 · How drugs use it
No product in this corpus aims at TDP-43 yet. Drugs bind the molecule precisely: to switch it off, flag the cell for the immune system, or deliver a payload.
External identifiers
Biology
RNA-binding protein that mislocalises in some FTD and related diseases.
Latest papers
topQuery for this target: (TITLE:"TDP-43" OR ABSTRACT:"TDP-43" OR TITLE:"TARDBP" OR ABSTRACT:"TARDBP") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about TDP-43, not a curated reading list.
Similar pages
not linked directly; found by shared links- TargetTau
Shares Frontotemporal dementia and the tag dementia-atlas.
- BottleneckWrong-subtype treatment
Shares Frontotemporal dementia and the tag dementia-atlas.
- DiagnosisDementia (umbrella)
Shares Frontotemporal dementia and the tag dementia-atlas.
- DiagnosisAlzheimer’s disease
Shares Frontotemporal dementia and the tag dementia-atlas.
